Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The University of Oxford and its partner organisations have been awarded funding that will support the training of over 175 bioscience graduate students as part of £170 million investment in bioscience by the BBSRC (Biotechnology and Biosciences Research Council, part of UK Research and Innovation).

Oxford-led doctoral training partnership to offer over 175 graduate scholarships in the biosciences © Shutterstock

The total investment will fund 1,700 PhD researchers over five annual cohorts at academic institutions all over the UK under the third phase of UKRI-BBSRC’s Doctoral Training Partnerships (DTP). The Oxford Interdisciplinary Bioscience DTP’s share will be over £14M, and matched funding by partner organisations and industry will bring the total investment in the Oxford partnership to over £20 million

This represents the third phase of BBSRC funding for Oxford’s Interdisciplinary Bioscience DTP programme, an innovative four-year DPhil/PhD programme that aims to equip a new generation of researchers with the skills, insight and knowledge needed to tackle the most important challenges in bioscience research, and develop the world-class, highly skilled workforce the UK needs for its future. Oxford’s Interdisciplinary Bioscience DTP was initially funded in 2012 and is part of the University of Oxford’s innovative, interdisciplinary Doctoral Training Centre.

The Oxford Interdisciplinary Bioscience DTP is led by the University of Oxford, in partnership with eight world-class research organisations. Six of these collaborations, The Pirbright Institute, Oxford Brookes University, Diamond Light Source, ISIS Neutron and Muon Source, STFC Central Laser Facility and the Research Complex at Harwell, continue the successful partnership established in the second phase of DTP funding. For the third phase two new organisations have joined the partnership, the Novo Nordisk Research Centre Oxford (NNRCO), an innovative target discovery and translational research institute which opened in Oxford in 2017; and the Rosalind Franklin Institute, a new national institute based at Harwell dedicated to transforming life science through interdisciplinary research and technology development.

Read more (University of Oxford website)

Similar stories

New research reveals relationship between particular brain circuits and different aspects of mental wellbeing

Researchers at the University of Oxford have uncovered previously unknown details about how changes in the brain contribute to changes in wellbeing.

Night-time blood pressure assessment is found to be important in diagnosing hypertension

Around 15% of people aged 40-75 may have a form of undiagnosed high blood pressure (hypertension) that occurs only at night-time. Because they do not know about this, and therefore are not being treated for it, they are at a higher risk of cardiovascular disease such as stroke, heart failure, and even death, suggests new research from the University of Oxford published in the British Journal of General Practice.

Major new NIHR Global Health Research Unit to focus on data science and genomic surveillance of antimicrobial resistance

The Centre for Genomic Pathogen Surveillance, part of the Big Data Institute at the University of Oxford, has been awarded funding worth £7m for their work as an NIHR Global Health Research Unit (GHRU) for the next five years. The Centre’s research and capacity building work focuses on delivering genomics and enabling data for the surveillance of antimicrobial resistance (AMR).

How artificial intelligence is shaping medical imaging

Dr Qiang Zhang of the Radcliffe Department of Medicine explains how artificial intelligence is being used to help researchers and physicians interpret medical imaging.

Researchers describe how cancer cells can defend themselves from the consequences of certain genetic defects

Researchers in Department of Physiology, Anatomy and Genetics have identified a rescue mechanism that allows cancers to overcome the consequences of inactivating mutations in critically important genes.